Simplex Trading
OTLK icon

Simplex Trading’s Outlook Therapeutics OTLK Stock Holding History

Simplex Trading’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$349 Sell
1,700
-6,600
-80% -$2.85K ﹤0.01% 8777
2025
Q4 		$13.1K Buy
+8,300
New +$13.3K ﹤0.01% 6811
2025
Q1 		– Sell
-2,000
Closed -$3K – 9344
2024
Q4 		$3K Sell
2,000
-2,100
-51% -$8.64K ﹤0.01% 7905
2024
Q3 		$21K Buy
4,100
+3,100
+310% +$22.7K ﹤0.01% 6646
2024
Q2 		$7K Buy
+1,000
New +$8.03K ﹤0.01% 7690

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Simplex Trading's OTLK Position: Q1 2026 in Review

Simplex Trading increased its Outlook Therapeutics (OTLK) stake by 25% in Q1 2026, buying an estimated $11.6K and bringing the position to 132,666 shares worth $27.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6483.

Simplex Trading first reported a position in OTLK in Q2 2024 and has held it in 4 quarters since. The position peaked at $167K in Q4 2025. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Simplex Trading held 132,666 shares of Outlook Therapeutics worth $27.3K as of Q1 2026.
  • Simplex Trading bought 26,869 Outlook Therapeutics shares in Q1 2026, an estimated $11.6K.
  • Outlook Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6483 holding.
  • Simplex Trading first reported a position in Outlook Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • Simplex Trading's Outlook Therapeutics position peaked at $167K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.